According to the report, the global calcium channel blocker market accounted for USD 11.26 billion in 2016 and is expected to reach USD 15.31 billion, growing at a CAGR of around 5.4% between 2017 and 2022.Calcium channel blockers are the chemical class of antihypertensive drugs used to treat various ill conditions of the heart and blood vessels. For example, CCB is commonly used in the treatment of angina pectoris, hypertension, and Reynaud’s phenomenon. Combination therapy is commonly used in the treatment of high blood pressure or angina pectoris.
[wptab name=’Report Description’ active=”1″ ]
According to the report, the global calcium channel blocker market accounted for USD 11.26 billion in 2016 and is expected to reach USD 15.31 billion, growing at a CAGR of around 5.4% between 2017 and 2022.
Calcium channel blockers (CCBs) or calcium antagonists are among the most widely used drugs in cardiovascular medicine. CCBs promote vasodilator activity and thus act by reducing calcium influx into vascular smooth muscle cells by interfering with voltage-operated calcium channels in the cell membrane. This activity of calcium channel blockers helps for treating Hypertension and various other cardiovascular diseases.
The market of global calcium channel blocker has been accelerated by rising prevalence of hypertension across the globe. Moreover, calcium channel blockers are an essential class of cardiovascular drug prescribed by a physician for the treatment of hypertension which helps in propelling the growth of calcium channel blocker market. Furthermore, its wide application in pharmaceutical industry is expected to fuel the growth of global calcium channel blocker market. As well, the rising percentage of the obese population is also considered as a major driving factor for the growth of CCB market. However, availability of alternatives and certain side effect of CCB can restrict the growth of calcium channel blocker market. Nonetheless, ongoing research and development and combination therapy will serve as major opportunities for upcoming growth of calcium channel blocker market.
Based on product, calcium channel blocker market segmented into two types: Dihydropyridine and Non-Dihydropyridine. Dihydropyridine market is further sub-segmented into Amlodipine, Cilnidipine, Felodipine, Verapamil, Diltiazem, Isradipine, Nicardipine, Nisoldipine, Nifedipine and others. In 2016, amlodipine held the largest market share in terms of total revenue generation in the Dihydropyridine market. This growth is attributed due to the most preference by the physician or consultant towards amlodipine over the other drugs.
Based on application, calcium channel blocker market segmented into five types: hypertension, angina pectoris, pregnancy, anti-obesity and other. Hypertension dominated the calcium channel blockers market in 2016. This segment accounted for the largest market share in term of revenue generation in 2016. The growth of hypertension market is attributed due to large hypertension patient population than any other illness which can be treated by CCB.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global calcium channel blocker include Pfizer Inc., AstraZeneca plc., bayer healthcare llc., GlaxoSmithKline plc., Sanofi S.A., Johnson & Johnson, Abcam, AbMole Bioscience, and Clearsynth.
[/wptab]
[wptab name=’Table of content’]
List of Figures
1. Market Research Process
2. Market Research Methodology
3. Global Calcium Channel Blocker Market Revenue, 2016 – 2022 (USD Million)
4. Porter’s Five Forces Analysis
5. Calcium Channel Blocker: Market Attractiveness Analysis, By Drug Class Segment
6. Calcium Channel Blocker: Market Attractiveness Analysis, By Application Segment
7. Calcium Channel Blocker: Market Attractiveness Analysis, By Regional Segment
8. Company Market Share Analysis, 2016 And 2022
9. Global Calcium Channel Blocker Market Revenue Share By Drug Class, 2016 And 2022
10. Calcium Channel Blocker Market For Dihydropyridine, 2016 – 2022, (USD Million)
11. Calcium Channel Blocker Market For Amlodipine, 2016 – 2022, (USD Million)
12. Calcium Channel Blocker Market For Cilnidipine, 2016 – 2022, (USD Million)
13. Calcium Channel Blocker Market For Felodipine, 2016 – 2022, (USD Million)
14. Calcium Channel Blocker Market For Isradipine, 2016 – 2022, (USD Million)
15. Calcium Channel Blocker Market For Nicardipine, 2016 – 2022, (USD Million)
16. Calcium Channel Blocker Market For Nisoldipine, 2016 – 2022, (USD Million)
17. Calcium Channel Blocker Market For Nifedipine, 2016 – 2022, (USD Million)
18. Calcium Channel Blocker Market For Others, 2016 – 2022, (USD Million)
19. Calcium Channel Blocker Market For Non-Dihydropyridine, 2016 – 2022, (USD Million)
20. Calcium Channel Blocker Market For Diltiazem, 2016 – 2022, (USD Million)
21. Calcium Channel Blocker Market For Verapamil, 2016 – 2022, (USD Million)
22. Global Calcium Channel Blocker Market Revenue Share By Application, 2016 And 2022
23. Calcium Channel Blocker Market For Angina Pectoris, 2016 – 2022, (USD Million)
24. Calcium Channel Blocker Market For Hypertension, 2016 – 2022, (USD Million)
25. Calcium Channel Blocker Market For Pregnancy, 2016 – 2022, (USD Million)
26. Calcium Channel Blocker Market For Obesity, 2016 – 2022, (USD Million)
27. Calcium Channel Blocker Market For Others, 2016 – 2022, (USD Million)
28. Global Calcium Channel Blocker Market Share, By Region, 2016 – 2022
29. North America Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
30. U.S. Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
31. Europe Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
32. Asia Pacific Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
33. China Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
34. Japan Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
35. Latin America Calcium Channel Blocker Market, 2016-2022, (USD Million)
36. Brazil Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
37. Middle East & Africa Calcium Channel Blocker Market, 2016 – 2022, (USD Million)
List of Tables
1. Calcium Channel Blocker Market: Market Snapshot
2. Drivers Of Global Calcium Channel Blocker Market: Impact Analysis
3. Restraints Of Global Calcium Channel Blocker Market: Impact Analysis
4. North America Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
5. North America Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
6. U.S. Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
7. U.S. Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
8. Europe Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
9. Europe Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
10. Asia Pacific Calcium Channel Blocker Market Revenue, By Drug Class 2016 – 2022(USD Million)
11. Asia Pacific Calcium Channel Blocker Market Revenue, By Application 2016 – 2022(USD Million)
12. Japan Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
13. Japan Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
14. India Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
15. India Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
16. Latin America Calcium Channel Blocker Market Revenue, By Drug Class – 2016 – 2022 (USD Million)
17. Latin America Calcium Channel Blocker Market Revenue, By Application – 2016 – 2022 (USD Million)
18. Brazil Calcium Channel Blocker Market Revenue, By Drug Class , 2016 – 2022(USD Million)
19. Brazil Calcium Channel Blocker Market Revenue, By Application, 2016 – 2022(USD Million)
20. Middle East And Africa Calcium Channel Blocker Market Revenue, By Drug Class 2016 – 2022 (USD Million)
21. Middle East And Africa Calcium Channel Blocker Market Revenue, By Application 2016 – 2022 (USD Million)
[/wptab]
[wptab name=’Request For Sample’]
[contact-form-7 id=”7″ title=”Request For Sample”]
[/wptab]
[end_wptabset]